Soft conductors are essential for advancing soft bioelectronics, as they provide the fundamental electrical pathways that enable reliable recording and stimulation in dynamic biological environments. Unlike conventional rigid conductors, which fail under repeated deformation and create mechanical mismatches with tissues, soft conductors combine electrical conductivity with intrinsic elasticity, thereby ensuring stable performance during continuous motion and strain. This unique adaptability not only minimizes tissue irritation but also enhances the fidelity of bioelectronic interfaces. Within this context, We are exploring diverse soft conductor form-factors, including fiber, ultra-thin films, and nano-composites.
Nanobiosensors are sophisticated analytical devices that combine nanotechnology with biological sensing elements to detect and analyze biological substances at the nanoscale. These devices play a crucial role in various fields, including healthcare, environmental monitoring, food safety, and biotechnology, by providing high sensitivity, selectivity, and rapid response times. By leveraging the unique properties of nanomaterials, nanobiosensors can identify minute concentrations of biomolecules, making them invaluable tools for early disease detection and precise monitoring of biological processes.
We have conducted research on three primary types of nanobiosensors: electrical biosensors, mechanical biosensors, and optical biosensors. Each type offers unique advantages and has distinct mechanisms for transducing biological interactions into measurable signals. We particularly interested in the application of these biosensors for blood-based disease diagnosis. Blood is a rich source of biomarkers, including proteins, metabolites, and genetic material, that provide crucial insights into an individual's health status. By employing nanobiosensors to analyze blood samples, it is possible to detect diseases at an early stage, monitor disease progression, and evaluate treatment efficacy with unprecedented precision.
We are deeply interested in the field of biomedical electronics, focusing on three key areas: blood-based diagnostics, disease diagnosis using physiological signals and biokinematics, and treatment and rehabilitation through electrical stimulation. Blood-based diagnostics involve utilizing advanced electronic systems to analyze biomarkers in blood samples, enabling early detection and monitoring of diseases such as cancer, diabetes, and cardiovascular disorders. By harnessing the power of electronic sensors and nanotechnology, we can develop highly sensitive diagnostic tools that offer rapid and accurate results. Additionally, I am fascinated by the potential of disease diagnosis through physiological signals and biokinematics, where biomedical electronics play a crucial role in monitoring vital signs and detecting abnormal physiological patterns. Techniques such as electrocardiography (ECG), electromyography (EMG), and motion analysis provide valuable insights into a patient's health, allowing for the diagnosis of conditions like arrhythmias, muscular disorders, and neurological diseases. Finally, I am committed to exploring the use of electrical stimulation for treatment and rehabilitation, where controlled electrical impulses are applied to tissues and nerves to promote healing and improve functionality. This approach is particularly beneficial for patients recovering from injuries, undergoing physical therapy, or managing chronic pain. By integrating cutting-edge electronic technologies with healthcare, I aim to contribute to the development of innovative solutions that enhance patient care and improve overall well-being.